An siRNA screen identifies CHD4 as a target for epigenetic therapy

被引：0
|
作者：
Okamoto, Yasuyuki [1 ]
Yamazaki, Jumpei [1 ]
Sato, Takahiro [1 ]
Cesaroni, Matteo [1 ]
Chung, Woonbok [1 ]
Garriga, Judith [1 ]
Jelinek, Jaroslav [1 ]
Katz, Richard A. [2 ]
Issa, Jean-Pierre [1 ]
机构：
[1] Temple Univ, Philadelphia, PA 19122 USA
[2] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-373
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
373
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The chromatin remodeler CHD4 as a potential specific target for alveolar rhabdomyosarcoma therapy
    Marques, Joana
    Boehm, Maria
    Wachtel, Marco
    Schaefer, Beat
    CANCER RESEARCH, 2016, 76
  • [2] Chromatin Remodulator CHD4: A Potential Target for Cancer Interception
    Goswami, Krishnendu
    Venkatachalam, Karthikkumar
    Singh, Surya P.
    Rao, Chinthalapally V.
    Madka, Venkateshwar
    GENES, 2025, 16 (02)
  • [3] Hepatocellular Carcinoma (HCC) CHD4: new Target for molecular Therapies
    Franke, Katharina
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2016, 54 (03): : 200 - 200
  • [4] Identification of CHD4 As a Potential Therapeutic Target of Acute Myeloid Leukemia
    Heshmati, Yaser
    Turkoez, Goezde
    Harisankar, Aditya
    Linnarsson, Sten
    Dimitriou, Marios
    Sinha, Indranil
    Lehmann, Soeren
    Qian, Hong
    Walfridsson, Julian
    BLOOD, 2016, 128 (22)
  • [5] CHD4, HIF, and Breast Cancer
    不详
    CANCER RESEARCH, 2020, 80 (18) : 3772 - 3772
  • [6] Epigenetic regulation of plastin 3 expression by the macrosatellite DXZ4 and the transcriptional regulator CHD4
    Strathmann, Eike A.
    Hoelker, Irmgard
    Tschernoster, Nikolai
    Hosseinibatkooie, Seyyedmohsen
    Come, Julien
    Martinat, Cecile
    Altmueller, Janine
    Wirth, Brunhilde
    AMERICAN JOURNAL OF HUMAN GENETICS, 2023, 110 (03) : 442 - 459
  • [7] siRNA screen identifies QPCT as a druggable target for Huntington's disease
    Jimenez-Sanchez, Maria
    Lam, Wun
    Hannus, Michael
    Soennichsen, Birte
    Imarisio, Sara
    Fleming, Angeleen
    Tarditi, Alessia
    Menzies, Fiona
    Dami, Teresa Ed
    Xu, Catherine
    Gonzalez-Couto, Eduardo
    Lazzeroni, Giulia
    Heitz, Freddy
    Diamanti, Daniela
    Massai, Luisa
    Satagopam, Venkata P.
    Marconi, Guido
    Caramelli, Chiara
    Nencini, Arianna
    Andreini, Matteo
    Sardone, Gian Luca
    Caradonna, Nicola P.
    Porcari, Valentina
    Scali, Carla
    Schneider, Reinhard
    Pollio, Giuseppe
    O'Kane, Cahir J.
    Caricasole, Andrea
    Rubinsztein, David C.
    NATURE CHEMICAL BIOLOGY, 2015, 11 (05) : 347 - U144
  • [8] SiRNA screen identifies QPCT as a druggable target for Huntington's disease
    Jimenez-Sanchez M.
    Lam W.
    Hannus M.
    Sönnichsen B.
    Imarisio S.
    Fleming A.
    Tarditi A.
    Menzies F.
    Ed Dami T.
    Xu C.
    Gonzalez-Couto E.
    Lazzeroni G.
    Heitz F.
    Diamanti D.
    Massai L.
    Satagopam V.P.
    Marconi G.
    Caramelli C.
    Nencini A.
    Andreini M.
    Sardone G.L.
    Caradonna N.P.
    Porcari V.
    Scali C.
    Schneider R.
    Pollio G.
    O'Kane C.J.
    Caricasole A.
    Rubinsztein D.C.
    Nature Chemical Biology, 2015, 11 (5) : 347 - 354
  • [9] The epigenetic factor CHD4 contributes to metastasis by regulating the EZH2/β-catenin axis and acts as a therapeutic target in ovarian cancer
    Wang, Jieyu
    Zhong, Fangfang
    Li, Jun
    Yue, Huiran
    Li, Wenzhi
    Lu, Xin
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [10] The epigenetic factor CHD4 contributes to metastasis by regulating the EZH2/β-catenin axis and acts as a therapeutic target in ovarian cancer
    Jieyu Wang
    Fangfang Zhong
    Jun Li
    Huiran Yue
    Wenzhi Li
    Xin Lu
    Journal of Translational Medicine, 21
12345